Cart
sales@molnova.com
Mast cell degranulating peptide (28-49)
CAS No. 65636-54-6
Mast cell degranulating peptide (28-49)( —— )
Catalog No. M30267 CAS No. 65636-54-6
Mast cell degranulating peptide (28-49) is a bee venom depolarizer that can improve the cGMP content of cerebellum tablets in mice.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameMast cell degranulating peptide (28-49)
-
NoteResearch use only, not for human use.
-
Brief DescriptionMast cell degranulating peptide (28-49) is a bee venom depolarizer that can improve the cGMP content of cerebellum tablets in mice.
-
DescriptionMast cell degranulating peptide (28-49) is a bee venom depolarizer that can improve the cGMP content of cerebellum tablets in mice.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorIC50: cGMP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number65636-54-6
-
Formula Weight2591.25
-
Molecular FormulaC110H196N40O24S4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:{Ile}{Lys}{Cys}{Asn}{Cys}{Lys}{Arg}{His}{Val}{Ile}{Lys}{Pro}{His}{Ile}{Cys}{Arg}{Lys}{Ile}{Cys}{Gly}{Lys}{Asn}-NH2
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Ahnert G, et al. Investigations on the mechanism of cyclic guanosine monophosphate increase due to depolarizing agents as studied with sea anemone toxin II in mouse cerebellar slices. Naunyn Schmiedebergs Arch Pharmacol. 1979 Jun;307(2):159-66.
molnova catalog
related products
-
NR2F6 modulator-1
NR2F6 modulator-1 is a potent modulator of nuclear receptor subfamily 2, group F, member 6 (NR2F6), used to study immune regulation and modulation of tumour stem cell activity.
-
Taurocholic Acid (so...
Taurocholic acid is a bile salt formed in the liver by conjugation of cholic acid with taurine that is involved in the emulsification of lipids.1.
-
pep2-EVKI
Inhibitor peptide that selectively disrupts binding of the AMPA receptor subunit GluA2 (at the C-terminal PDZ site) to protein interacting with C kinase (PICK1). Does not affect binding of GluA2 to GRIP or ABP and does not increase AMPA current amplitude or affect long term depression (LTD).
